ST段抬高型心肌梗死临床实践指南引用的系统评价方法学质量参差不齐
本研究评估了国际ST段抬高型心肌梗死(STEMI)临床实践指南推荐所依据的系统评价(SR)的方法学质量与报告清晰度。检索13个指南数据库后纳入4部指南,从中提取71篇独特SR,用AMSTAR和PRISMA评分。SR的AMSTAR评分为1分(低)至9分(高)(11分制),所有指南在基金来源披露、偏倚风险和发表偏倚方面均表现不足;PRISMA清单完整性为44%至96%。仅1篇SR被全部4部指南引用,且所有指南都遗漏了其他指南引用的大量可用SR。
要点
- 4部STEMI指南共引用71篇独特系统评价,其AMSTAR评分为1分(低)至9分(高)(11分制)。
- 所有指南在基金来源披露、偏倚风险评估和发表偏倚方面均表现不足。
- PRISMA清单完整性为44%至96%,SRs未提供完整检索策略、研究方案与注册、发表偏倚评估或基金来源报告。
- 仅1篇系统评价被全部4部指南引用,所有指南都遗漏了其他指南引用的大量可用系统评价。
- 指南制定者已认识到这种变异性,但作者认为这仍是需要进一步解决的显著问题。
研究设计与关键结果
- 研究为方法学质量评估,检索13个指南数据库(包括美国国家指南库和指南国际网络),纳入4部与STEMI管理相关、由管理机构或国家组织认可、以英文撰写的临床实践指南。从参考文献中提取71篇独特系统评价,由两名研究者用AMSTAR和PRISMA评分。SRs的AMSTAR评分为1分(低)至9分(高)(11分制);所有指南在基金来源披露、偏倚风险和发表偏倚方面均表现不足;PRISMA清单完整性为44%至96%;仅1篇SR被全部4部指南引用;所有指南都遗漏了其他指南引用的大量可用SR。
证据类型、等级与局限
- 证据类型为对指南所引用系统评价的方法学质量评估。局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The objective of this study was to assess the methodological quality and clarity of reporting of the systematic reviews (SRs) supporting clinical practice guideline (CPG) recommendations in the management of ST-elevation myocardial infarction (STEMI) across international CPGs.
METHODS: We searched 13 guideline clearinghouses including the National Guideline Clearinghouse and Guidelines International Network (GIN). To meet inclusion criteria CPGs must be pertinent to the management of STEMI, endorsed by a governing body or national organization, and written in English. We retrieved SRs from the reference sections using a combination of keywords and hand searching. Two investigators scored eligible SRs using AMSTAR and PRISMA.
RESULTS: We included four CPGs. We extracted 71 unique SRs. These SRs received AMSTAR scores ranging from 1 (low) to 9 (high) on an 11-point scale. All CPGs consistently underperformed in areas including disclosure of funding sources, risk of bias, and publication bias according to AMSTAR. PRISMA checklist completeness ranged from 44% to 96%. The PRISMA scores indicated that SRs did not provide a full search strategy, study protocol and registration, assessment of publication bias or report funding sources. Only one SR was referenced in all four CPGs. All CPGs omitted a large subset of available SRs cited by other guidelines.
CONCLUSIONS: Our study demonstrates the variable quality of SRs used to establish recommendations within guidelines included in our sample. Although guideline developers have acknowledged this variability, it remains a significant finding that needs to be addressed further.
FUNDING: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
参考来源
- Scott J, Howard B, Sinnett P, et al. Variable methodological quality and use found in systematic reviews referenced in STEMI clinical practice guidelines. Am J Emerg Med. 2017. PMID: 28623004. doi:10.1016/j.ajem.2017.06.010
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。